Related Experiment Video
Updated: Apr 27, 2026
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.9K
Atopic dermatitis, melatonin, and sleep disturbance
Yung-Sen Chang1, Yen-Ting Chou2, Jyh-Hong Lee3
1Department of Pediatrics, Taipei City Hospital Renai Branch, Taipei City, Taiwan;
Pediatrics
|July 16, 2014
Summary
Children with atopic dermatitis (AD) experience significant sleep disturbances, including reduced sleep efficiency. Disease severity, measured by the Scoring Atopic Dermatitis index, can predict poor sleep quality in pediatric AD patients.
Area of Science:
- Pediatric Dermatology
- Sleep Medicine
- Immunology
Background:
- Sleep disturbance is prevalent in children with atopic dermatitis (AD), but its objective characteristics and underlying causes are not well understood.
- Previous research relied heavily on subjective questionnaires, limiting insights into the pathophysiology of sleep issues in AD.
Purpose of the Study:
- To objectively characterize sleep disturbances in children with AD using actigraphy and polysomnography.
- To identify contributing factors and clinical predictors of sleep problems in pediatric AD patients.
Main Methods:
- Sleep parameters were assessed using actigraphy and polysomnography in 72 children with AD and 32 controls (ages 1-18).
- Biomarkers including urinary 6-sulfatoxymelatonin, serum cytokines, and total and specific immunoglobulin E (IgE) levels were measured.
Main Results:
- Children with AD exhibited significantly reduced sleep efficiency, prolonged sleep onset latency, increased sleep fragmentation, and decreased non-rapid eye movement sleep.
- AD disease severity correlated with sleep disturbance (r = 0.55-0.7), with a Scoring Atopic Dermatitis index ≥48.7 predicting poor sleep efficiency (AUC = 0.81).
- Lower nocturnal melatonin, pruritus, scratching, elevated total IgE, and sensitization to dust mites/staphylococcal enterotoxins were associated with sleep disturbance.
Conclusions:
- Poor sleep efficiency is a common objective finding in children with AD, predictable by disease severity.
- Melatonin and IgE levels may play a role in AD-related sleep disturbances.
- Actigraphy is a valuable tool for evaluating sleep issues in pediatric AD.
Keywords:
IgESCORADactigraphyatopic dermatitisdust mitemelatoninpolysomnographysleep disturbancestaphylococcal enterotoxinMore Related Videos
Related Concept Videos
01:19Management of Insomnia
768
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
768
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
957
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
957
01:07Narcolepsy
881
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
881
01:27Insomnia
616
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
616
01:15REM Sleep Behavior Disorder
2.9K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.9K
02:19Circadian Rhythms and Gene Regulation
3.4K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
3.4K